Biology subjects

Clement, L.

Publications and source records attributed to Clement, L..

25 records · Page 2Linked to original sources

bioRxiv2019

MSqRob takes the missing hurdle: uniting intensity- and count-based proteomics

Missing values are a major issue in quantitative data-dependent mass spectrometry-based proteomics. We therefore present an innovative solution to this key issue by introducing a hurdle model, which is a mixture between a binomial peptide count and a peptide intensity-based model component. It enables dramatically enhanced quantification of proteins with many missing values without having to resort to harmful assumptions for missingness. We demonstrate the superior performance of our method by comparing it with state-of-the-art methods in the field.

bioinformatics↗

bioRxiv2019

Robust summarization and inference in proteome-wide label-free quantification

Label-Free Quantitative mass spectrometry based workflows for differential expression (DE) analysis of proteins impose important challenges on the data analysis due to peptide-specific effects and context dependent missingness of peptide intensities. Peptide-based workflows, like MSqRob, test for DE directly from peptide intensities and outper-form summarization methods which first aggregate MS1 peptide intensities to protein intensities before DE analysis. However, these methods are computationally expensive, often hard to understand for the non-specialised end-user, and do not provide protein summaries, which are important for visualisation or downstream processing. In this work, we therefore evaluate state-of-the-art summarization strategies using a benchmark spike-in dataset and discuss why and when these fail compared to the state-of-the-art peptide based model, MSqRob. Based on this evaluation, we propose a novel summarization strategy, MSqRob-Sum, which estimates MSqRobs model parameters in a two-stage procedure circumventing the drawbacks of peptide-based workflows. MSqRobSum maintains MSqRobs superior performance, while providing useful protein expression summaries for plotting and downstream analysis. Summarising peptide to protein intensities considerably reduces the computational complexity, the memory footprint and the model complexity, and makes it easier to disseminate DE inferred on protein summaries. Moreover, MSqRobSum provides a highly modular analysis framework, which provides researchers with full flexibility to develop data analysis workflows tailored towards their specific applications.

bioinformatics↗

bioRxiv2019

Trajectory-based differential expression analysis for single-cell sequencing data

Trajectory inference has radically enhanced single-cell RNA-seq research by enabling the study of dynamic changes in gene expression levels during biological processes such as the cell cycle, cell type differentiation, and cellular activation. Downstream of trajectory inference, it is vital to discover genes that are associated with the lineages in the trajectory to illuminate the underlying biological processes. Furthermore, genes that are differentially expressed between developmental/activational lineages might be highly relevant to further unravel the system under study. Current data analysis procedures, however, typically cluster cells and assess differential expression between the clusters, which fails to exploit the continuous resolution provided by trajectory inference to its full potential. The few available non-cluster-based methods only assess broad differences in gene expression between lineages, hence failing to pinpoint the exact types of divergence. We introduce a powerful generalized additive model framework based on the negative binomial distribution that allows flexible inference of (i) within-lineage differential expression by detecting associations between gene expression and pseudotime over an entire lineage or by comparing gene expression between points/regions within the lineage and (ii) between-lineage differential expression by comparing gene expression between lineages over the entire lineages or at specific points/regions. By incorporating observation-level weights, the model additionally allows to account for zero inflation, commonly observed in single-cell RNA-seq data from full-length protocols. We evaluate the method on simulated and real datasets from droplet-based and full-length protocols, and show that the flexible inference framework is capable of yielding biological insights through a clear interpretation of the data.

bioinformatics↗

bioRxiv2018

Observation weights to unlock bulk RNA-seq tools for zero inflation and single-cell applications

Dropout events in single-cell transcriptome sequencing (scRNA-seq) cause many transcripts to go undetected and induce an excess of zero read counts, leading to power issues in differential expression (DE) analysis. This has triggered the development of bespoke scRNA-seq DE methods to cope with zero inflation. Recent evaluations, however, have shown that dedicated scRNA-seq tools provide no advantage compared to traditional bulk RNA-seq tools. We introduce a weighting strategy, based on a zero-inflated negative binomial (ZINB) model, that identifies excess zero counts and generates gene and cell-specific weights to unlock bulk RNA-seq DE pipelines for zero-inflated data, boosting performance for scRNA-seq.

bioinformatics↗

bioRxiv2017

zingeR: unlocking RNA-seq tools for zero-inflation and single cell applications

Dropout in single cell RNA-seq (scRNA-seq) applications causes many transcripts to go undetected. It induces excess zero counts, which leads to power issues in differential expression (DE) analysis and has triggered the development of bespoke scRNA-seq DE tools that cope with zero-inflation. Recent evaluations, however, have shown that dedicated scRNA-seq tools provide no advantage compared to traditional bulk RNA-seq tools. We introduce zingeR, a zero-inflated negative binomial model that identifies excess zero counts and generates observation weights to unlock bulk RNA-seq pipelines for zero-inflation, boosting performance in scRNA-seq differential expression analysis.

bioinformatics↗

bioRxiv2017

Mass spectrometrists should search for all peptides, but assess only the ones they care about

In shotgun proteomics identified mass spectra that are deemed irrelevant to the scientific hypothesis are often discarded. Noble (2015) 1 therefore urged researchers to remove irrelevant peptides from the database prior to searching to improve statistical power. We here however, argue that both the classical as well as Nobles revised method produce suboptimal peptide identifications and have problems in controlling the false discovery rate (FDR). Instead, we show that searching for all expected peptides, and removing irrelevant peptides prior to FDR calculation results in more reliable identifications at controlled FDR level than the classical strategy that discards irrelevant peptides post FDR calculation, or than Nobles strategy that discards irrelevant peptides prior to searching.

bioinformatics↗

bioRxiv2017

A general and powerful stage-wise testing procedure for differential expression and differential transcript usage

BackgroundReductions in sequencing cost and innovations in expression quantification have prompted an emergence of RNA-seq studies with complex designs and data analysis at transcript resolution. These applications involve multiple hypotheses per gene, leading to challenging multiple testing problems. Conventional approaches provide separate top-lists for every contrast and false discovery rate (FDR) control at individual hypothesis level. Hence, they fail to establish proper gene-level error control, which compromises downstream validation experiments. Tests that aggregate individual hypotheses are more powerful and provide gene-level FDR control, but in the RNA-seq literature no methods are available for post-hoc analysis of individual hypotheses.\n\nResultsWe introduce a two-stage procedure that leverages the increased power of aggregated hypothesis tests while maintaining high biological resolution by post-hoc analysis of genes passing the screening hypothesis. Our method is evaluated on simulated and real RNA-seq experiments. It provides gene-level FDR control in studies with complex designs while boosting power for interaction effects without compromising the discovery of main effects. In a differential transcript usage/expression context, stage-wise testing gains power by aggregating hypotheses at the gene level, while providing transcript-level assessment of genes passing the screening stage. Finally, a prostate cancer case study highlights the relevance of combining gene with transcript level results.\n\nConclusionStage-wise testing is a general paradigm that can be adopted whenever individual hypotheses can be aggregated. In our context, it achieves an optimal middle ground between biological resolution and statistical power while providing gene-level FDR control, which is beneficial for downstream biological interpretation and validation.

bioinformatics↗